These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 10074199)
1. Recombinant respiratory syncytial virus bearing a deletion of either the NS2 or SH gene is attenuated in chimpanzees. Whitehead SS; Bukreyev A; Teng MN; Firestone CY; St Claire M; Elkins WR; Collins PL; Murphy BR J Virol; 1999 Apr; 73(4):3438-42. PubMed ID: 10074199 [TBL] [Abstract][Full Text] [Related]
2. Recombinant respiratory syncytial virus that does not express the NS1 or M2-2 protein is highly attenuated and immunogenic in chimpanzees. Teng MN; Whitehead SS; Bermingham A; St Claire M; Elkins WR; Murphy BR; Collins PL J Virol; 2000 Oct; 74(19):9317-21. PubMed ID: 10982380 [TBL] [Abstract][Full Text] [Related]
3. Replacement of the F and G proteins of respiratory syncytial virus (RSV) subgroup A with those of subgroup B generates chimeric live attenuated RSV subgroup B vaccine candidates. Whitehead SS; Hill MG; Firestone CY; St Claire M; Elkins WR; Murphy BR; Collins PL J Virol; 1999 Dec; 73(12):9773-80. PubMed ID: 10559287 [TBL] [Abstract][Full Text] [Related]
4. Respiratory syncytial virus modified by deletions of the NS2 gene and amino acid S1313 of the L polymerase protein is a temperature-sensitive, live-attenuated vaccine candidate that is phenotypically stable at physiological temperature. Luongo C; Winter CC; Collins PL; Buchholz UJ J Virol; 2013 Feb; 87(4):1985-96. PubMed ID: 23236065 [TBL] [Abstract][Full Text] [Related]
5. Recombinant respiratory syncytial viruses with deletions in the NS1, NS2, SH, and M2-2 genes are attenuated in vitro and in vivo. Jin H; Zhou H; Cheng X; Tang R; Munoz M; Nguyen N Virology; 2000 Jul; 273(1):210-8. PubMed ID: 10891423 [TBL] [Abstract][Full Text] [Related]
6. Chimeric bovine respiratory syncytial virus with glycoprotein gene substitutions from human respiratory syncytial virus (HRSV): effects on host range and evaluation as a live-attenuated HRSV vaccine. Buchholz UJ; Granzow H; Schuldt K; Whitehead SS; Murphy BR; Collins PL J Virol; 2000 Feb; 74(3):1187-99. PubMed ID: 10627529 [TBL] [Abstract][Full Text] [Related]
7. Addition of a missense mutation present in the L gene of respiratory syncytial virus (RSV) cpts530/1030 to RSV vaccine candidate cpts248/404 increases its attenuation and temperature sensitivity. Whitehead SS; Firestone CY; Karron RA; Crowe JE; Elkins WR; Collins PL; Murphy BR J Virol; 1999 Feb; 73(2):871-7. PubMed ID: 9882287 [TBL] [Abstract][Full Text] [Related]
8. A comparison in chimpanzees of the immunogenicity and efficacy of live attenuated respiratory syncytial virus (RSV) temperature-sensitive mutant vaccines and vaccinia virus recombinants that express the surface glycoproteins of RSV. Crowe JE; Collins PL; London WT; Chanock RM; Murphy BR Vaccine; 1993 Nov; 11(14):1395-404. PubMed ID: 8310760 [TBL] [Abstract][Full Text] [Related]
9. Refining the balance of attenuation and immunogenicity of respiratory syncytial virus by targeted codon deoptimization of virulence genes. Meng J; Lee S; Hotard AL; Moore ML mBio; 2014 Sep; 5(5):e01704-14. PubMed ID: 25249281 [TBL] [Abstract][Full Text] [Related]
10. Partial Attenuation of Respiratory Syncytial Virus with a Deletion of a Small Hydrophobic Gene Is Associated with Elevated Interleukin-1β Responses. Russell RF; McDonald JU; Ivanova M; Zhong Z; Bukreyev A; Tregoning JS J Virol; 2015 Sep; 89(17):8974-81. PubMed ID: 26085154 [TBL] [Abstract][Full Text] [Related]
11. Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants. Karron RA; Wright PF; Belshe RB; Thumar B; Casey R; Newman F; Polack FP; Randolph VB; Deatly A; Hackell J; Gruber W; Murphy BR; Collins PL J Infect Dis; 2005 Apr; 191(7):1093-104. PubMed ID: 15747245 [TBL] [Abstract][Full Text] [Related]
12. A cold-passaged, attenuated strain of human respiratory syncytial virus contains mutations in the F and L genes. Connors M; Crowe JE; Firestone CY; Murphy BR; Collins PL Virology; 1995 Apr; 208(2):478-84. PubMed ID: 7747420 [TBL] [Abstract][Full Text] [Related]
13. Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant. Karron RA; Buonagurio DA; Georgiu AF; Whitehead SS; Adamus JE; Clements-Mann ML; Harris DO; Randolph VB; Udem SA; Murphy BR; Sidhu MS Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13961-6. PubMed ID: 9391135 [TBL] [Abstract][Full Text] [Related]
14. Respiratory syncytial virus that lacks open reading frame 2 of the M2 gene (M2-2) has altered growth characteristics and is attenuated in rodents. Jin H; Cheng X; Zhou HZ; Li S; Seddiqui A J Virol; 2000 Jan; 74(1):74-82. PubMed ID: 10590093 [TBL] [Abstract][Full Text] [Related]
15. Attenuation of the recombinant human parainfluenza virus type 3 cp45 candidate vaccine virus is augmented by importation of the respiratory syncytial virus cpts530 L polymerase mutation. Skiadopoulos MH; Surman SR; St Claire M; Elkins WR; Collins PL; Murphy BR Virology; 1999 Jul; 260(1):125-35. PubMed ID: 10405364 [TBL] [Abstract][Full Text] [Related]
16. Chimeric subgroup A respiratory syncytial virus with the glycoproteins substituted by those of subgroup B and RSV without the M2-2 gene are attenuated in African green monkeys. Cheng X; Zhou H; Tang RS; Munoz MG; Jin H Virology; 2001 Apr; 283(1):59-68. PubMed ID: 11312662 [TBL] [Abstract][Full Text] [Related]
17. Recombinant respiratory syncytial virus from which the entire SH gene has been deleted grows efficiently in cell culture and exhibits site-specific attenuation in the respiratory tract of the mouse. Bukreyev A; Whitehead SS; Murphy BR; Collins PL J Virol; 1997 Dec; 71(12):8973-82. PubMed ID: 9371553 [TBL] [Abstract][Full Text] [Related]
18. Recombinant respiratory syncytial virus (RSV) bearing a set of mutations from cold-passaged RSV is attenuated in chimpanzees. Whitehead SS; Juhasz K; Firestone CY; Collins PL; Murphy BR J Virol; 1998 May; 72(5):4467-71. PubMed ID: 9557743 [TBL] [Abstract][Full Text] [Related]
19. Identification of Respiratory Syncytial Virus Nonstructural Protein 2 Residues Essential for Exploitation of the Host Ubiquitin System and Inhibition of Innate Immune Responses. Whelan JN; Tran KC; van Rossum DB; Teng MN J Virol; 2016 Jul; 90(14):6453-6463. PubMed ID: 27147743 [TBL] [Abstract][Full Text] [Related]
20. The interferon antagonist NS2 protein of respiratory syncytial virus is an important virulence determinant for humans. Wright PF; Karron RA; Madhi SA; Treanor JJ; King JC; O'Shea A; Ikizler MR; Zhu Y; Collins PL; Cutland C; Randolph VB; Deatly AM; Hackell JG; Gruber WC; Murphy BR J Infect Dis; 2006 Feb; 193(4):573-81. PubMed ID: 16425137 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]